IHS Chemical Week

Regions :: Western Europe :: Germany

H.C. Starck Financial Performance Surges in 2011, Owners Mull Sale or IPO

1:29 PM MDT | April 3, 2012 | Sotirios Frantzanas

H.C. Starck's Ebitda increased 90% for full year 2011, to €190 million ($253 million ), according to figures published by Reuters citing sources close to H.C. Starck. H.C. Starck has not commented on the leaked Ebitda figures. The company has published sales figures showing that its 2011 sales increased 28% to €883.2 million compared with €689.3 million in 2010. The owners of the company, private equity groups Advent and Carlyle, are seeking to sell the group or to launch an IPO, sources told Reuters.  The owners of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa